FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138080281> ?p ?o ?g. }

• W2138080281 endingPage "1725" @default.
• W2138080281 startingPage "1716" @default.
• W2138080281 abstract "Diabetic nephropathy has become the major cause of end-stage renal disease (ESRD) in the western world and is forecast to become the most frequent cause of ESRD in the African continent and in developing countries in other areas.A discussion to achieve a consensus on key points relating to diabetic nephropathy.Given the catastrophic consequences of diabetes not only for renal function but also for the cardiovascular system, major efforts should be aimed at prevention. The cornerstone of primary prevention (development of microalbuminuria) is a tight control of blood pressure and blood glucose. Although ACE inhibitors have proved effective in preventing the development of microalbuminuria in normotensive patients, this is not the case, in comparison with other classes of antihypertensive drugs, in those who are hypertensive but normoalbuminuric. Secondary prevention (transition to overt nephropathy) and tertiary prevention (progression of established nephropathy to ESRD) benefit from the use of inhibitors of the renin-angiotensin system, whilst the role of tight glycaemic control is more controversial at these stages. Therapeutic lifestyle changes are also important. They should include body weight control combined with regular physical exercise, cessation of smoking and reduced salt intake. The pathogenesis of diabetic nephropathy and its association with hypertension, accelerating renal damage, is complex. It involves genetic factors, altered renal sodium handling with sodium retention, metabolic disturbances and oxidative stress with the formation of advanced-glycation end products (AGEs) and reactive oxygen species.Although the awareness of the importance of normalizing blood pressure levels and tight glycaemic control have allowed improved survival of diabetic patients, the mortality excess remains unacceptably high in patients with diabetic nephropathy. New treatment strategies are under investigation, including inhibitors of AGE formation, protein kinase C inhibitors, antioxidants, glycosaminoglycans, PPAR-gamma agonists and COX-2 inhibitors." @default.
• W2138080281 created "2016-06-24" @default.
• W2138080281 creator A5071768099 @default.
• W2138080281 date "2003-09-01" @default.
• W2138080281 modified "2023-10-14" @default.
• W2138080281 title "The importance of diabetic nephropathy in current nephrological practice" @default.
• W2138080281 cites W13069992 @default.
• W2138080281 cites W1924198296 @default.
• W2138080281 cites W1946047130 @default.
• W2138080281 cites W1988363812 @default.
• W2138080281 cites W1991626886 @default.
• W2138080281 cites W1995407151 @default.
• W2138080281 cites W1995937915 @default.
• W2138080281 cites W1999917583 @default.
• W2138080281 cites W2001921597 @default.
• W2138080281 cites W2004582643 @default.
• W2138080281 cites W2023362855 @default.
• W2138080281 cites W2043828707 @default.
• W2138080281 cites W2044773944 @default.
• W2138080281 cites W2050069527 @default.
• W2138080281 cites W2051679072 @default.
• W2138080281 cites W2056518876 @default.
• W2138080281 cites W2056976690 @default.
• W2138080281 cites W2058726697 @default.
• W2138080281 cites W2063450352 @default.
• W2138080281 cites W2069246794 @default.
• W2138080281 cites W2070712710 @default.
• W2138080281 cites W2071386040 @default.
• W2138080281 cites W2075080893 @default.
• W2138080281 cites W2077112764 @default.
• W2138080281 cites W2079508487 @default.
• W2138080281 cites W2085341182 @default.
• W2138080281 cites W2086428765 @default.
• W2138080281 cites W2090955625 @default.
• W2138080281 cites W2093721306 @default.
• W2138080281 cites W2094813393 @default.
• W2138080281 cites W2095970471 @default.
• W2138080281 cites W2100526574 @default.
• W2138080281 cites W2102552397 @default.
• W2138080281 cites W2106537990 @default.
• W2138080281 cites W2108834825 @default.
• W2138080281 cites W2112321301 @default.
• W2138080281 cites W2113596742 @default.
• W2138080281 cites W2119491358 @default.
• W2138080281 cites W2131176334 @default.
• W2138080281 cites W2138119952 @default.
• W2138080281 cites W2145920701 @default.
• W2138080281 cites W2151920020 @default.
• W2138080281 cites W2153674927 @default.
• W2138080281 cites W2157606645 @default.
• W2138080281 cites W2157928663 @default.
• W2138080281 cites W2161624379 @default.
• W2138080281 cites W2182260120 @default.
• W2138080281 cites W2203067263 @default.
• W2138080281 cites W2312229371 @default.
• W2138080281 cites W2325609900 @default.
• W2138080281 cites W2325754393 @default.
• W2138080281 cites W2335631045 @default.
• W2138080281 cites W2340171512 @default.
• W2138080281 cites W2410332845 @default.
• W2138080281 cites W2416370211 @default.
• W2138080281 cites W2615684303 @default.
• W2138080281 cites W2993043209 @default.
• W2138080281 cites W2003670762 @default.
• W2138080281 cites W2004270119 @default.
• W2138080281 cites W2319268509 @default.
• W2138080281 doi "https://doi.org/10.1093/ndt/gfg288" @default.
• W2138080281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12937216" @default.
• W2138080281 hasPublicationYear "2003" @default.
• W2138080281 type Work @default.
• W2138080281 sameAs 2138080281 @default.
• W2138080281 citedByCount "58" @default.
• W2138080281 countsByYear W21380802812012 @default.
• W2138080281 countsByYear W21380802812013 @default.
• W2138080281 countsByYear W21380802812014 @default.
• W2138080281 countsByYear W21380802812015 @default.
• W2138080281 countsByYear W21380802812016 @default.
• W2138080281 countsByYear W21380802812017 @default.
• W2138080281 countsByYear W21380802812018 @default.
• W2138080281 countsByYear W21380802812019 @default.
• W2138080281 countsByYear W21380802812020 @default.
• W2138080281 countsByYear W21380802812021 @default.
• W2138080281 countsByYear W21380802812022 @default.
• W2138080281 crossrefType "journal-article" @default.
• W2138080281 hasAuthorship W2138080281A5071768099 @default.
• W2138080281 hasBestOaLocation W21380802811 @default.
• W2138080281 hasConcept C126322002 @default.
• W2138080281 hasConcept C134018914 @default.
• W2138080281 hasConcept C147990577 @default.
• W2138080281 hasConcept C177713679 @default.
• W2138080281 hasConcept C2778653478 @default.
• W2138080281 hasConcept C2779134260 @default.
• W2138080281 hasConcept C2779922275 @default.
• W2138080281 hasConcept C2781184683 @default.
• W2138080281 hasConcept C2781203188 @default.
• W2138080281 hasConcept C555293320 @default.
• W2138080281 hasConcept C71924100 @default.
• W2138080281 hasConcept C84393581 @default.

• next